T Stamp Inc. Chief Executive Officer Gareth Genner purchased 1,000 shares of Class A common stock on August 21, 2026, according to a regulatory filing. The transaction, valued at $3,210, was executed at $3.21 per share.
Following the acquisition, Genner holds 151,075 shares of T Stamp’s Class A common stock directly. The filing was signed on his behalf by Lance Wilson under a limited power of attorney dated January 2, 2025.
T Stamp’s stock has surged 27% over the past week, trading with high price volatility, according to InvestingPro data. The company’s market capitalization stands at $18.05 million. T Stamp remains unprofitable, reporting a loss per share of $2.04 over the last twelve months.
Recent developments at T Stamp include the filing of a provisional patent application for a new AI technology designed to address confirmation bias and hallucinations in medical diagnostics. The system, titled Medical Diagnostic Assurance System, aims to enhance reliability in AI-assisted medical decision-making.
Additionally, the company completed its first sovereign large language model project for an international telecommunications client. The project focused on a compliance-related AI model operating on the client’s own servers to ensure data security and privacy.
